Supplemental tables and figures "An RNAi-based screening of clinically relevant transcription factors regulating human adipogenesis and adipocyte metabolism"

These are supplemental tables and figures to the study ""An RNAi-based phenotypic screening of clinically relevant transcription factors regulating human adipogenesis and adipocyte metabolism"The abstract: <b>Objective </b>Healthy hyperplasic (many but smaller fat cells) white adipose tissue (WAT) expansion is mediated by recruitment, proliferation and/or differentiation of new fat cells. This process (adipogenesis) is controlled by transcriptional programs mostly identified in rodents. A systemic investigation of adipogenic human transcription factors (TFs) that are relevant for metabolic conditions has not been revealed previously. <b>Methods </b>TFs regulated in WAT by obesity, adipose morphology, cancer cachexia and insulin resistance were selected from microarrays. Their role in differentiation of human adipose tissue-derived stem cells (hASC) was investigated by RNA interference (RNAi) screen. Lipid accumulation, cell number and lipolysis were measured for all screened factors (148 TFs). RNA (RNAseq), protein (western blot) expression, insulin and catecholamine responsiveness were examined in hASC following siRNA treatment of selected target TFs.<b> </b> <b>Results </b>Analysis of TFs regulated by metabolic conditions in human WAT revealed that many of them belong to adipogenesis-regulating pathways. The RNAi screen identified 39 genes that affected fat cell differentiation <i>in vitro</i>, where 11 genes were novel. Of the latter JARID2 stood out as being necessary for formation of healthy fat cell metabolic phenotype by regulating expression of multiple fat-cell phenotype-specific genes. <b>Conclusions </b>This comprehensive RNAi screening in hASC suggests that a large proportion of WAT TFs that are impacted by metabolic conditions might be important for hyperplastic adipose tissue expansion. The screen also identified JARID2 as a novel TF essential for the development of functional adipocytes. @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman"; mso-ansi-language:SV; mso-fareast-language:SV;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:Latha; mso-bidi-theme-font:minor-bidi; mso-ansi-language:SV; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}